Literature DB >> 29935163

Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization Is Up-Regulated and Involved in Hyaluronan Degradation in Human Osteoarthritic Cartilage.

Hidenori Shimizu1, Masayuki Shimoda2, Satsuki Mochizuki2, Yuka Miyamae2, Hitoshi Abe2, Miyuki Chijiiwa2, Hiroyuki Yoshida3, Jun Shiozawa4, Muneaki Ishijima4, Kazuo Kaneko4, Arihiko Kanaji5, Masaya Nakamura5, Yoshiaki Toyama5, Yasunori Okada6.   

Abstract

Hyaluronan (HA)-binding protein involved in HA depolymerization (HYBID), also called cell migration-inducing protein (CEMIP; alias KIAA1199), plays a key role in the degradation of HA in skin and arthritic synovial fibroblasts, but its functions in osteoarthritic (OA) cartilage remain elusive. Here, we investigated the expression and roles of HYBID in human OA cartilage. HYBID was highly expressed by chondrocytes in the HA-depleted area of OA cartilage, and HYBID immunoreactivity was correlated with Mankin score, the histopathologic severity of OA lesions of cartilage. Real-time quantitative PCR indicated that HYBID expression was significantly higher in OA cartilage than in control cartilage. In addition, OA chondrocytes exhibited HA-degrading activity, which was abolished by knock-down of HYBID by siRNAs. Although OA chondrocytes also expressed certain levels of hyaluronidases 1 and 2 and CD44, knock-down of these molecules exhibited negligible effects on HA degradation. Double immunostaining of HYBID and clathrin heavy chain revealed that HYBID was localized in the clathrin-coated vesicles, and HA was endocytosed within the vesicles of OA chondrocytes. Among eight factors including cytokines and growth factors examined, only tumor necrosis factor α stimulated OA chondrocytes to overexpress HYBID. These data are the first to demonstrate that HYBID is up-regulated in OA cartilage, and suggest that tumor necrosis factor α-stimulated HYBID plays a role in HA degradation in OA cartilage.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29935163     DOI: 10.1016/j.ajpath.2018.05.012

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  8 in total

1.  Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase.

Authors:  Hiroshi Koike; Yoshihiro Nishida; Tamayuki Shinomura; Bisei Ohkawara; Kinji Ohno; Lisheng Zhuo; Koji Kimata; Takahiro Ushida; Shiro Imagama
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

2.  CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane.

Authors:  Michel G Malaise; Dominique de Seny; Céline Deroyer; Christophe Poulet; Geneviève Paulissen; Federica Ciregia; Olivier Malaise; Zelda Plener; Gaël Cobraiville; Christophe Daniel; Philippe Gillet
Journal:  Cell Mol Life Sci       Date:  2022-04-27       Impact factor: 9.207

Review 3.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

4.  CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes.

Authors:  Céline Deroyer; Edith Charlier; Sophie Neuville; Olivier Malaise; Philippe Gillet; William Kurth; Alain Chariot; Michel Malaise; Dominique de Seny
Journal:  Cell Death Dis       Date:  2019-02-04       Impact factor: 8.469

5.  The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.

Authors:  Hanxue Sun; Sanyukta Rana; Zhe Wang; Kun Zhao; Martina Schnölzer; Jan Provaznik; Thilo Hackert; Qingjie Lv; Margot Zöller
Journal:  J Oncol       Date:  2019-08-07       Impact factor: 4.375

6.  Induction of CEMIP in Chondrocytes by Inflammatory Cytokines: Underlying Mechanisms and Potential Involvement in Osteoarthritis.

Authors:  Takashi Ohtsuki; Omer F Hatipoglu; Keiichi Asano; Junko Inagaki; Keiichiro Nishida; Satoshi Hirohata
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

Review 7.  Engineering Hyaluronic Acid for the Development of New Treatment Strategies for Osteoarthritis.

Authors:  Yu Seon Kim; Farshid Guilak
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

8.  Expression and regulation of recently discovered hyaluronidases, HYBID and TMEM2, in chondrocytes from knee osteoarthritic cartilage.

Authors:  Jun Shiozawa; Susana de Vega; Chiho Yoshinaga; Xang Ji; Yoshifumi Negishi; Masahiro Momoeda; Tomomi Nakamura; Hiroyuki Yoshida; Haruka Kaneko; Muneaki Ishijima; Yasunori Okada
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.